GeneDx Holdings Corp. (WGS)

NMS – Real vaqt narxi. Valyuta: USD

82.05

+0.31 (0.38%)

Bozor ochiq: Aug 12, 2026, 11:50 AM EDT

80.11

-1.63 (-1.99%)

Oldingi bozordan keyin: Aug 11, 2026, 7:58 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

GeneDx Holdings Corp. (WGS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

GeneDx Holdings Corp. (WGS)

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Search stocks

GeneDx Holdings Corp. (WGS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

GeneDx Holdings Corp. (WGS)

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx to Participate in Upcoming Investor Conferences

Alger Small Cap Focus Fund Q2 2026 Portfolio Review

GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript

GeneDx Q2 Earnings Call Highlights

GeneDx Holdings Corp. (WGS) Q2 Earnings and Revenues Surpass Estimates

GeneDx Reports Second Quarter 2026 Financial Results

Videolar

No Data

Press-relizlar

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

GeneDx Reports Second Quarter 2026 Financial Results

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026